The Trip Report cover image

#38 Hailey Gilmore: The Complexity of Psychedelic Science

The Trip Report

CHAPTER

Navigating Psychedelic Therapy and FDA Regulations

This chapter explores the integration of psychedelic therapy within the healthcare system, particularly its interaction with regulatory bodies like the FDA. It highlights the challenges in proving efficacy and safety for treatment-resistant depression while discussing alternative trial designs and off-label practices. The conversation also emphasizes the need for tailored mental health services alongside psychedelic treatments, advocating for a nuanced approach to drug approvals without compromising patient safety.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner